Articles tagged: NanoBio
NanoBio raises $11 million in new round of funding
Posted: Nov 29, 2012With the closing of an $11 million Series C funding round, Ann Arbor-based biotechnology company NanoBio has now raised more than $130 million in funding. The company was founded in 2000 as a University of ... Read more »
NanoBio chooses CEO with experience in acquisitions and public offerings
Posted: Oct 11, 2012David Peralta, who joined NanoBio in 2006 as chief financial officer, will take over as the chief executive officer of NanoBio Corporation from its founder. Dr. James Baker, who founded the company in 2000 as ... Read more »
Ann Arbor biotech firm NanoBio awarded critical patent
Posted: Feb 02, 2010Ann Arbor-based biotechnology firm NanoBio Corp. has received a U.S. patent that solidifies intellectual property rights considered key to its top products, the company announced today. NanoBio, a University of Michigan spinoff firm, was awarded ... Read more »
Ann Arbor's NanoBio strikes multimillion-dollar licensing deal with GlaxoSmithKline
Posted: Dec 16, 2009Ann Arbor-based NanoBio Corp. announced today that it's signed an agreement with United Kingdom-based pharmaceutical giant GlaxoSmithKline to license its cold sore treatment still in clinical development. The deal provides $14.5 million upfront to NanoBio in ... Read more »
Swine flu vaccine production problems show NanoBio's potential
Posted: Nov 01, 2009The sluggish production process for the swine flu vaccine illustrates the global potential of an Ann Arbor biotech company’s technology. Antiquated vaccine production technology, which is making it difficult for manufacturers to quickly produce H1N1 ... Read more »
NanoBio, University of Michigan land joint grant worth $9.3 million
Posted: Oct 13, 2009By Nathan Bomey and Tina Reed, AnnArbor.comA nanotechnology partnership between the University of Michigan and Ann Arbor-based NanoBio Corp. got a $9.3 million boost today, officials said. The National Institutes of Health awarded the grant ... Read more »
Ann Arbor venture capitalist: FDA scrutiny could impede innovation
Posted: Aug 13, 2009Increasing regulatory scrutiny from the U.S. Food and Drug Administration didn’t scare Venture Investors away from funding Ann Arbor-based biotech startup NanoBio Corp. in July. But Venture Investors, which has an Ann Arbor office and ... Read more »
Get the Ann Arbor RSS Feed
AnnArbor.com